Myelodysplastic Myeloproliferative Neoplasm Unclassifiable
📧 Sign up to get email alerts when something new happens for Myelodysplastic Myeloproliferative Neoplasm Unclassifiable.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm [Phase 2]
This Phase 2 trial update reports completion of a study evaluating the combination of ruxolitinib phosphate and azacitidine in patients with…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN [Phase 1]
This Phase 1 trial update reports adding venetoclax to fludarabine and busulfan conditioning before transplant and to maintenance therapy fo…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders [Phase 1, Phase 2]
The document notes the completion of a Phase 1/2 clinical trial evaluating tipifarnib in patients with chronic myeloid leukemia, chronic mye…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial evaluating donor peripheral blood stem cell transplantation in combination with pretargeted radioimmunotherapy for patients wi…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Aflibercept in Treating Patients With Myelodysplastic Syndromes [Phase 2]
A Phase 2 study of aflibercept in patients with various myelodysplastic syndromes was terminated, with results posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases [Phase 1]
Phase 1 trial update on belinostat plus azacitidine in adults with advanced hematologic cancers. The study has completed enrollment and eval…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases [Phase 1]
This Phase 1 trial evaluates the safety and feasibility of combining vorinostat with decitabine in adults with relapsed, refractory, or poor…